Compare POOL & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POOL | RGEN |
|---|---|---|
| Founded | 1993 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.6B |
| IPO Year | 1997 | 1995 |
| Metric | POOL | RGEN |
|---|---|---|
| Price | $210.67 | $144.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $274.43 | $167.67 |
| AVG Volume (30 Days) | ★ 1.0M | 992.3K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | ★ 1.45 | 0.15 |
| Revenue | ★ $5,289,396,000.00 | $141,236,000.00 |
| Revenue This Year | $4.30 | $14.30 |
| Revenue Next Year | $3.84 | $14.52 |
| P/E Ratio | ★ $143.40 | $959.67 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $172.68 | $100.99 |
| 52 Week High | $345.00 | $175.77 |
| Indicator | POOL | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 57.81 | 62.11 |
| Support Level | $195.49 | $141.44 |
| Resistance Level | $224.41 | $149.05 |
| Average True Range (ATR) | 6.84 | 6.40 |
| MACD | -0.08 | 0.07 |
| Stochastic Oscillator | 61.86 | 80.80 |
Pool Corp is a wholesale distributor of swimming pool supplies, equipment, and related leisure products. The company's products include pool pumps, filters, heaters, and cleaners; pool maintenance products like chemicals, supplies, and repair parts; irrigation and landscape maintenance products; and outdoor lighting, grills, outdoor kitchen components, etc. These products are offered through branded distribution networks such as Horizon, SCP, Poolcorp Commercial Aquatics, Sun Wholesale Supply, Superior Pool Products, and NPT. The company's customers include pool builders, pool service companies, retail stores, commercial pool operators, and landscape contractors. Geographically, it generates maximum revenue from the United States, followed by other markets like Europe and Australia.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.